ABMT (Advanced BioMedical Technologies) Total Liabilities: $8.58 Mil (As of Jul. 2021)


What is Advanced BioMedical Technologies Total Liabilities?

Advanced BioMedical Technologies ABMT Total Liabilities is $8.58 Mil as of Jul. 2021.

Advanced BioMedical Technologies's Total Liabilities for the quarter that ended in Jul. 2021 was $8.58 Mil.

Advanced BioMedical Technologies's quarterly Total Liabilities increased from Jan. 2021 ($8.17 Mil) to Apr. 2021 ($8.35 Mil) and increased from Apr. 2021 ($8.35 Mil) to Jul. 2021 ($8.58 Mil).

Advanced BioMedical Technologies's annual Total Liabilities increased from Oct. 2018 ($5.76 Mil) to Oct. 2019 ($6.70 Mil) and increased from Oct. 2019 ($6.70 Mil) to Oct. 2020 ($7.87 Mil).

Advanced BioMedical Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Total Liabilities Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 5.08 5.76 6.70 7.87

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.28 7.87 8.17 8.35 8.58

Advanced BioMedical Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Advanced BioMedical Technologies's Total Liabilities for the fiscal year that ended in Oct. 2020 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.864+(0.007+5.611830444785E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=7.87

Total Liabilities=Total Assets (A: Oct. 2020 )-Total Equity (A: Oct. 2020 )
=0.469--7.402
=7.87

Advanced BioMedical Technologies's Total Liabilities for the quarter that ended in Jul. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.579+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=8.58

Total Liabilities=Total Assets (Q: Jul. 2021 )-Total Equity (Q: Jul. 2021 )
=0.397--8.182
=8.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $8.58 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Total Liabilities of $8.58 Mil as of Jul. 2021. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Total Liabilities too high?
Advanced BioMedical Technologies' current Total Liabilities is $8.58 Mil.
How does Advanced BioMedical Technologies' Total Liabilities compare to VYCO and ADMT?
Advanced BioMedical Technologies' Total Liabilities of $8.58 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Total Liabilities is $8.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Total Liabilities of $8.58 Mil. The current Total Liabilities is $8.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Total Liabilities is $8.58 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.